What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
His primary areas of study are Cytotoxic T cell, Cell biology, T cell, Immunology and IL-2 receptor.
His Cytotoxic T cell research is multidisciplinary, incorporating perspectives in Molecular biology and T-cell receptor.
The Cell biology study combines topics in areas such as Acquired immune system, Apoptosis, Innate immune system and Tumor necrosis factor alpha.
His work on FOXP3, Antigen recognition and Missing self as part of his general Immunology study is frequently connected to Natural and Cognitive science, thereby bridging the divide between different branches of science.
Dieter Kabelitz has included themes like Interleukin 6 and Cytokine in his IL-2 receptor study.
His work deals with themes such as Natural killer T cell, CD28 and Antigen-presenting cell, which intersect with Interleukin 21.
His most cited work include:
- Compartmentalization of TNF Receptor 1 Signaling: Internalized TNF Receptosomes as Death Signaling Vesicles (427 citations)
- Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells (315 citations)
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 (277 citations)
What are the main themes of his work throughout his whole career to date?
Dieter Kabelitz mainly investigates Immunology, Cell biology, T cell, Cytotoxic T cell and Antigen.
The various areas that Dieter Kabelitz examines in his Cell biology study include Apoptosis, Immunological synapse and Fas receptor.
Dieter Kabelitz interconnects Cell, Immunosurveillance and Cytokine in the investigation of issues within T cell.
His Cytotoxic T cell study frequently involves adjacent topics like Molecular biology.
His Molecular biology research incorporates themes from NKG2D and CD3.
His Interleukin 21 research is multidisciplinary, incorporating elements of Natural killer T cell and Interleukin 12.
He most often published in these fields:
- Immunology (39.20%)
- Cell biology (30.80%)
- T cell (30.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (16.40%)
- Immune system (16.40%)
- T cell (30.00%)
In recent papers he was focusing on the following fields of study:
Dieter Kabelitz focuses on Cancer research, Immune system, T cell, Immunotherapy and Cytotoxic T cell.
His research in Cancer research intersects with topics in Cancer cell, Cytokine, Cytotoxicity and Cancer immunotherapy.
Immune system is a subfield of Immunology that Dieter Kabelitz explores.
His Immunology study combines topics in areas such as Organ system and Ulcerative colitis.
He is interested in T-cell receptor, which is a field of T cell.
His Cytotoxic T cell research integrates issues from Effector, Cell biology and FOXP3.
Between 2018 and 2021, his most popular works were:
- Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease (64 citations)
- An update on immune dysregulation in obesity-related insulin resistance. (24 citations)
- Vitamin C promotes the proliferation and effector functions of human γδ T cells (21 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
Cancer research, Immune system, T cell, Cytokine and Immunology are his primary areas of study.
The study incorporates disciplines such as Cytotoxic T cell and Antigen in addition to Cancer research.
Dieter Kabelitz works on Cytotoxic T cell which deals in particular with Granzyme B.
His Immune system research includes elements of Cell cycle and Cell biology, Effector.
His primary area of study in T cell is in the field of T-cell receptor.
His studies deal with areas such as Vedolizumab and Ulcerative colitis as well as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
